HealthcareNYSEsmall
Institutional-grade research for retail investors
SEC EDGAR: CIK 1860543CDRE stock profile & AI dashboard →

13F Pro Quality Score

57.4/100

Rank #1,100 of 2,962 stocksTOP 50%

View Healthcare peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Nov 14, 2026.

Revenue Growth

69.1/100

Profitability

45.8/100

Balance Sheet

66.1/100

Earnings Quality

86.6/100

Free Cash Flow

58.5/100

Institutional Flow

56.6/100

Revenue Scale

42.5/100

Dilution Risk

40.4/100
Email me the moment this company reports earnings
AI Research Report
Two-page plain-English analysis: business, thesis, and three scenarios for the next two years. Refreshed every quarter.
Upgrade to Pro
Pro: 5 reports/month · Pro+: unlimitedOpinion, not investment advice. Do your own research.

CDRE Stock Analysis & AI Quality Score

Data updated 2026-09-11

AI stock analysis and institutional research for Cadre Holdings, Inc. (CDRE), a Healthcare sector company. 13F Pro's AI-powered ranking engine scores CDRE at 57.4/100 on a 32-signal composite quality model, placing it at rank #1,100 of 2,962 stocks — the top half of the AI-ranked universe. CDRE scores in the top quartile across earnings quality (86.6). Shareholder dilution risk is elevated at 40.4/100, reflecting ongoing share issuance or stock-based compensation. Based on the latest XBRL financial filings (Q2 2026), Cadre Holdings, Inc. reports quarterly revenue of $207.1M, net income of $11.4M, an operating margin of 10.8%. Top institutional holders of CDRE by reported 13-F value include BlackRock, Greenhouse Funds LLLP, REINHART PARTNERS, based on the most recent SEC filings. CDRE trades on the NYSE exchange and files with the SEC under CIK 1860543. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate CDRE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Cadre Holdings, Inc. directly from SEC EDGAR. Cadre Holdings, Inc.'s 13F Pro composite quality score has ranged between 32 and 63 since 2022, currently 57.4 — an improving long-term trajectory across 61 quarterly and live scoring snapshots.

Fun facts about Cadre Holdings, Inc.

Quirks, history, and lore behind CDRE — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. defense and public-safety equipment company · small-cap · listed on the NYSE · headquartered in Florida.
  • 2
    The Numbers
    Annual revenue in the range of $500–600 million, with a business built almost entirely on selling protective gear and duty equipment to government and law-enforcement customers.
  • 3
    The History
    The company was taken public relatively recently — IPO in 2021 — but its roots go back decades through a string of acquisitions of specialized safety brands.
  • 4
    The Secret
    Despite being classified under healthcare, its real customers are police officers, corrections officers, and military personnel — people who need armor, not aspirin.
  • 5
    The Lore
    The company serves as a one-stop shop for duty gear, supplying everything from body armor and ballistic helmets to handcuffs and holsters under a portfolio of acquired brands.
  • 6
    The Giveaway
    Its very name hints at its mission — a cadre of products protecting those who protect us — and its ticker, CDRE, trades on the NYSE out of Jacksonville.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q2 2026

$207.1M

Net Income

Q2 2026

$11.4M

Free Cash Flow

Q2 2026

$18.7M

Operating Margin

Q2 2026

10.8%

ROIC

Q2 2026

12.1%

D/E Ratio

Q2 2026

1.14

Period

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro

Revenue

+7.5% YoY
$610.3MFY 2025
FY22 $457.8MFY23 $482.5MFY24 $567.6MFY25 $610.3M

Net Income

+22.2% YoY
$44.1MFY 2025
FY22 $5.8MFY23 $38.6MFY24 $36.1MFY25 $44.1M

Operating Income

+0.9% YoY
$67.4MFY 2025
FY22 $16.7MFY23 $56.5MFY24 $66.8MFY25 $67.4M

EPS (Diluted)

+13.3% YoY
$1.02FY 2025
FY22 $0.16FY23 $1.02FY24 $0.90FY25 $1.02

Total Assets

+18.0% YoY
$770.0MFY 2025
FY22 $392.0MFY23 $431.2MFY24 $652.7MFY25 $770.0M

Total Debt

+37.9% YoY
$323.5MFY 2025
FY22 $164.1MFY23 $154.6MFY24 $234.6MFY25 $323.5M

Op. Cash Flow

+100.5% YoY
$63.7MFY 2025
FY22 $46.4MFY23 $73.2MFY24 $31.8MFY25 $63.7M

Free Cash Flow

+117.7% YoY
$56.8MFY 2025
FY22 $41.9MFY23 $66.5MFY24 $26.1MFY25 $56.8M

Get alerted when CDRE's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for Cadre Holdings, Inc. including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of CDRE

Companies Similar to CDRE

Ranked by quality-profile closeness and shared hedge-fund ownership — not just sector membership.

NATR

NATURES SUNSHINE PRODUCTS INC

51
AI score
Similar quality profile · 3 shared holders
USPH

U S PHYSICAL THERAPY INC /NV

55
AI score
Similar quality profile · 2 shared holders
ATRC

AtriCure, Inc.

56
AI score
Similar quality profile · 4 shared holders
VMD

VIEMED HEALTHCARE, INC.

58
AI score
Similar quality profile · 3 shared holders
ADUS

Addus HomeCare Corp

65
AI score
Similar quality profile · 6 shared holders
MMSI

MERIT MEDICAL SYSTEMS INC

62
AI score
Similar quality profile · 2 shared holders
BFAM

BRIGHT HORIZONS FAMILY SOLUTIONS INC.

59
AI score
Similar quality profile · 6 shared holders
LFST

LifeStance Health Group, Inc.

60
AI score
Similar quality profile · 1 shared holders

Similarity is computed from the 8 composite sub-scores and latest-quarter 13F conviction holdings (index-style filers excluded). Refreshed monthly.

Put CDRE on your watchlist

Track score changes the day Cadre Holdings, Inc. files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is CDRE a good stock to buy?

13F Pro's AI-powered analysis of Cadre Holdings, Inc. (CDRE) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Healthcare sector (listed on NYSE). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for CDRE are available on the CDRE stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing. CDRE is classified as a small company.

Which hedge funds own CDRE?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling CDRE. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of Cadre Holdings, Inc.'s investment landscape.